Metabolic associated fatty liver disease
Conditions
Interventions
Control group:Professional clinicians will provide offline health education and lifestyle (diet and exercise) guidance according to the latest version of the Chinese MAFLD prevention and treatment gui
Intervention group:The clinicians participating in the study evaluated the study subjects through the 'fatty liver data analysis and management software (doctor's side)', and formulated a diet and exe
Sponsors
Chongqing Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Meet the 2024 diagnostic criteria for MAFLD; 2.No gender restrictions, aged 18 - 65 years old, with a body mass index (BMI) of 24 kg/m^2 <=BMI <=35 kg/m^2; 3.Patients should have a smartphone that meets the operating environment requirements of the software program in this study, and be capable of using the software program in this study under guidance; 4.Patients agree to participate in this study, accept re - examinations and follow - ups on time, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Genetic metabolic or autoimmune liver diseases, combined with hepatotropic virus and non - hepatotropic virus infections. Drug/toxin/alcoholic/biliary - origin liver injury, liver cirrhosis or any end - stage liver diseases; 2.Liver or extra - hepatic malignant tumors; 3.Diabetic patients with unstable blood sugar control (patients treated with insulin, HbA1C > 9%); 4.Pregnant and lactating women; 5.Patients with other major cardiovascular and cerebrovascular diseases (acute myocardial infarction, heart failure, malignant arrhythmia, stroke, cerebral hemorrhage), and those with liver and kidney failure; 6.Patients with severe respiratory diseases, who are unable to complete diet and exercise interventions and require other treatments; 7.Patients with mental and psychological diseases, including those in an anxious or depressive state; 8.Subjects who researchers believe have factors unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver fat attenuation parameters;Liver hardness value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight;Waistline;Hip circumference; | — |
Countries
China
Contacts
Public ContactYi Huang
Chongqing Traditional Chinese Medicine Hospital
Outcome results
None listed